Jesús Duque‐Afonso

1.6k total citations
46 papers, 1.1k citations indexed

About

Jesús Duque‐Afonso is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jesús Duque‐Afonso has authored 46 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 23 papers in Molecular Biology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jesús Duque‐Afonso's work include Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). Jesús Duque‐Afonso is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Acute Lymphoblastic Leukemia research (11 papers). Jesús Duque‐Afonso collaborates with scholars based in Germany, United States and Canada. Jesús Duque‐Afonso's co-authors include Michael Lübbert, Michael L. Cleary, Stephen H.K. Wong, Dietmar Pfeifer, Masayuki Iwasaki, Dominik Schneidawind, Nadja Blagitko‐Dorfs, Julia Karbach, Elke Jäger and Jürgen Finke and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Jesús Duque‐Afonso

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesús Duque‐Afonso Germany 18 684 468 225 161 148 46 1.1k
Maria Askmyr Sweden 12 311 0.5× 392 0.8× 206 0.9× 203 1.3× 163 1.1× 23 810
Justine E. Roderick United States 14 715 1.0× 244 0.5× 256 1.1× 452 2.8× 230 1.6× 22 1.2k
Lars Klemm United States 11 425 0.6× 220 0.5× 189 0.8× 185 1.1× 246 1.7× 34 818
Jette Ford Australia 19 470 0.7× 248 0.5× 148 0.7× 167 1.0× 323 2.2× 40 896
Alan Burnett United Kingdom 8 977 1.4× 856 1.8× 165 0.7× 132 0.8× 182 1.2× 14 1.4k
Benjamin Mizukawa United States 14 394 0.6× 400 0.9× 168 0.7× 161 1.0× 60 0.4× 37 737
Anand Jillella United States 12 456 0.7× 379 0.8× 166 0.7× 136 0.8× 43 0.3× 48 841
Patrick Hayden Ireland 19 558 0.8× 415 0.9× 346 1.5× 68 0.4× 63 0.4× 53 996
Yixiao Gong United States 10 574 0.8× 285 0.6× 189 0.8× 162 1.0× 69 0.5× 14 915
Sebastien A. Burel United States 15 972 1.4× 452 1.0× 109 0.5× 149 0.9× 49 0.3× 23 1.2k

Countries citing papers authored by Jesús Duque‐Afonso

Since Specialization
Citations

This map shows the geographic impact of Jesús Duque‐Afonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Duque‐Afonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Duque‐Afonso more than expected).

Fields of papers citing papers by Jesús Duque‐Afonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Duque‐Afonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Duque‐Afonso. The network helps show where Jesús Duque‐Afonso may publish in the future.

Co-authorship network of co-authors of Jesús Duque‐Afonso

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Duque‐Afonso. A scholar is included among the top collaborators of Jesús Duque‐Afonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Duque‐Afonso. Jesús Duque‐Afonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maqbool, Khurram, Roger Kramer, Hassan Foroughi Asl, et al.. (2025). Genomic determinants of therapy response in ETV6::RUNX1 leukemia. Leukemia. 39(9). 2125–2139.
2.
Kalweit, Gabriel, Diógenes Infante, Ruud Berger, et al.. (2025). Leveraging a foundation model zoo for cell similarity search in oncological microscopy across devices. Frontiers in Oncology. 15. 1480384–1480384.
3.
Cóndor, Mar, et al.. (2025). Leveraging automated time-lapse microscopy coupled with deep learning to automate colony forming assay. Frontiers in Oncology. 15. 1520972–1520972. 2 indexed citations
4.
Duque‐Afonso, Jesús, Jan Mitschke, Gabriele Greve, et al.. (2024). Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia. International Journal of Cancer. 155(11). 2068–2079.
5.
Farrokhi, Ali, Maryam Aletaha, Ana Márquez, et al.. (2024). Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia. Blood. 144(8). 809–821.
6.
Duque‐Afonso, Jesús, Gabriele Ihorst, Claudia Wehr, et al.. (2024). Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens. Bone Marrow Transplantation. 59(12). 1744–1753.
7.
Greve, Gabriele, Miguel Waterhouse, Robert Zeiser, et al.. (2023). Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. Cancers. 15(17). 4328–4328. 1 indexed citations
8.
Ihorst, Gabriele, Jesús Duque‐Afonso, Ralph Wäsch, et al.. (2023). Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure. Blood Cancer Journal. 13(1). 179–179. 5 indexed citations
9.
Farrokhi, Ali, et al.. (2023). Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations. Blood Advances. 7(22). 7087–7099. 1 indexed citations
10.
Uhl, Franziska E., Tobias Schmidt, Kyuho Han, et al.. (2022). Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia. Cancer Gene Therapy. 29(11). 1751–1760. 14 indexed citations
11.
Greil, Christine, Monika Engelhardt, Gabriele Ihorst, et al.. (2020). Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia. Bone Marrow Transplantation. 56(4). 841–852. 14 indexed citations
12.
Duque‐Afonso, Jesús, Kyuho Han, David W. Morgens, et al.. (2018). CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia. Cancer Research. 78(22). 6497–6508. 12 indexed citations
13.
Waterhouse, Miguel, Dietmar Pfeifer, Jesús Duque‐Afonso, et al.. (2018). Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation. Clinical Chemistry and Laboratory Medicine (CCLM). 57(5). 641–647. 28 indexed citations
14.
Zhu, Li, Qin Li, Stephen H.K. Wong, et al.. (2016). ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia. Cancer Discovery. 6(7). 770–783. 112 indexed citations
15.
Duque‐Afonso, Jesús, Michael C. Wei, Jue Feng, et al.. (2016). E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia. Cancer Research. 76(23). 6937–6949. 27 indexed citations
16.
Wong, Stephen H.K., David L. Goode, Masayuki Iwasaki, et al.. (2015). The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential. Cancer Cell. 28(2). 198–209. 103 indexed citations
17.
Duque‐Afonso, Jesús, Gabriele Ihorst, Ralph Wäsch, et al.. (2013). Identification of risk factors for bronchiolitis obliterans syndrome after reduced toxicity conditioning before hematopoietic cell transplantation. Bone Marrow Transplantation. 48(8). 1098–1103. 17 indexed citations
18.
Kuo, Hsu-Ping, Zhong Wang, Dung‐Fang Lee, et al.. (2013). Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB. Cancer Cell. 24(4). 423–437. 63 indexed citations
19.
Duque‐Afonso, Jesús, et al.. (2011). The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO. Oncogene. 30(27). 3062–3072. 38 indexed citations
20.
Duque‐Afonso, Jesús, Michaela Wagner, Michael Lübbert, et al.. (2009). Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes. Clinical Cancer Research. 15(11). 3705–3715. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026